Organization | R. Richard Sloop, M. D.

R. Richard Sloop, M. D. Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial

2008

NCT00636519

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2008

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 1 Trials (2)

botulism antitoxin bivalent (equine) types a and b (1 trial)

botulism antitoxin heptavalent (a, b, c, d, e, f, g) - (equine) (BAT) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Botulism (Phase 1)

Paralysis (Phase 1)

Overview

Highest Phase: Phase 1
# of Trials: 1
# of Trial APIs: 2